NASDAQ: CGON
Cg Oncology Inc Stock Ownership - Who owns Cg Oncology?

Insider buying vs selling

Have Cg Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leonard E. PostDirector2025-03-171,000$28.00
$28.00kSell
Leonard E. PostDirector2025-03-171,000$0.60
$600.00Buy
Leonard E. PostDirector2025-02-181,000$0.60
$600.00Buy
Leonard E. PostDirector2025-02-181,000$28.61
$28.61kSell
Leonard E. PostDirector2025-01-131,000$29.66
$29.66kSell
Leonard E. PostDirector2025-01-131,000$0.60
$600.00Buy
Hong Fang SongDirector2024-12-16700,000$28.00
$19.60MSell
Leonard E. PostDirector2024-12-161,000$0.60
$600.00Buy
Leonard E. PostDirector2024-12-161,000$28.84
$28.84kSell
Leonard E. PostDirector2024-12-061,000$0.60
$600.00Buy

1 of 2

CGON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGON insiders and whales buy or sell their stock.

CGON Shareholders

What type of owners hold Cg Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital LLC8.36%6,371,669$131.51MInstitution
Vanguard Group Inc7.69%5,861,082$120.97MInstitution
Decheng Capital Global Life Sciences Fund IV LP7.03%5,358,810$110.61MInsider
Hong Fang Song5.52%4,204,841$86.79MInsider
Blackrock Inc5.33%4,061,130$83.82MInstitution
Tcg Crossover Management LLC4.82%3,670,206$75.75MInstitution
Braidwell LP4.31%3,283,317$67.77MInstitution
Kynam Capital Management LP3.31%2,519,705$52.01MInstitution
Fmr LLC3.19%2,433,593$50.23MInstitution
Foresite Capital Management VI LLC2.91%2,221,474$45.85MInstitution

1 of 3

CGON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGON86.88%12.60%Net SellingNet Buying
AGIO75.63%24.37%Net SellingNet Selling
BCRX80.21%17.75%Net BuyingNet Selling
BEAM81.81%18.19%Net SellingNet Selling
ARWR79.12%10.88%Net SellingNet Selling

Cg Oncology Stock Ownership FAQ

Who owns Cg Oncology?

Cg Oncology (NASDAQ: CGON) is owned by 86.88% institutional shareholders, 12.60% Cg Oncology insiders, and 0.52% retail investors. Decheng Capital Global Life Sciences Fund IV LP is the largest individual Cg Oncology shareholder, owning 5.36M shares representing 7.03% of the company. Decheng Capital Global Life Sciences Fund IV LP's Cg Oncology shares are currently valued at $109.37M.

If you're new to stock investing, here's how to buy Cg Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.